Spermatogenesis-associated protein 31A7 (SPATA31A7)

Spermatogenesis-associated protein 31A7 is a human protein coded by the SPATA31A7 gene, predicted to be involved in cell differentiation and spermatogenesis, and is likely localized to cellular membranes. There is no established role as a therapeutic target, and the biological function remains only predicted, with no robust evidence for involvement in signaling pathways, disease, or direct functional characterization as a receptor, enzyme, or other canonical drug target class. The gene is protein-coding, with the UniProt accession Q8IWB4, and has a predicted length of 1347 amino acids. Aliases include former gene symbols and alternative names in various resources, but no evidence of receptor or enzyme function. The only known biological associations are with spermatogenesis and cell differentiation, based on sequence homology and gene-function predictions. There are no known drugs, mechanisms of action, or biomarker applications associated with SPATA31A7. There are also no described safety concerns or therapeutic challenges, as it is not established or pursued as a clinical target. Disease links in databases are based on genomic associations rather than direct functional evidence (e.g., possible links to adult spinal cord ependymoma and intellectual disability), but these are not well-characterized and do not reflect "target" status. Reports suggest membrane localization, but this is based on prediction rather than direct experimental confirmation.

Other names

FAM75A4FAM75A7SPATA31A4Protein FAM75A7AEP1C9orf36C9orf36AProtein FAM75A4